Deeply saddened by the loss of Stephen Harrison, one of the most influential leaders in hepatology. His legacy remains with us for ever. We offer our deepest condolences to his family for their loss.

✨Attention #MASH community!✨Share your experiences in our 2024 survey on Steatotic (Fatty) Liver Care in America. Your insights are vital! Participate anonymously and help shape future care. Details here➡️rb.gy/p2t4nc
#patientvoice #livertwitter #MAFLD #MetALD #NASH

New in The Innovation Medicine! New-onset age of metabolic-associated fatty liver disease and incident cardiovascular diseases Findings from prospective cohort.
Based on a large prospective cohort study, Zheng et al. aimed to examine the association between MAFLD and the risk of

This #worldliverday , help us shape the future of liver care by participating in our #MAFLD #MASH patient survey, as announced in our press release. Share your experiences and help improve treatment and support for all!➡️shorturl.at/AFGJ0 #StepUpForLiverHealth #livertwitter

Dear colleagues and friends, we're excited to share our recent article: MAFLD predicts cardiovascular disease risk better than MASLD.

'Steatotic liver disease-associated all-cause/cause-specific mortality in the United States' - read at bit.ly/3JCdk9T
#SLD #Livertwitter #MAFLD

🤔Will the contention over the semantic definition between MASLD and MAFLD ever end?

📖But... Did you know that the most common mistake in transcriping ancient books was to exchange 's' with 'f' ?

Check this letter by Paolo Angeli 👇

journal-of-hepatology.eu/article/S0168-…

Rezdiffra's approval includes a diet and exercise requirement. Discover effective diet strategies to optimize your health with my latest blog➡️rb.gy/b0rbit
#liverhealth #livertwitter #MAFLD #MASH #NAFLD #NASH #MetALD

Excited to receive the KWF Young Investigator Grant! With this funding we will unravel the intricate and reciprocal relationship between fatty liver, metabolism, and cancer development. benedetta artegiani #organoids #MAFLD #livercancer #grant #kwf

MAFLD, with its focus on metabolic dysfunctions rather than moderate alcohol use, serves as a better predictor of ASCVD than MASLD. This distinction highlights the importance of recognizing and addressing metabolic health as a crucial component of cardiovascular risk management.

🚨🚨 #MAFLD
MAFLD-related hepatocellular carcinoma

🆕 meta-analysis; 56,565 individuals with HCC.

📌Total MAFLD HCC prevalence : 48.7%
📌Single MAFLD HCC prevalence: 12.4%.

➡️ MAFLD is common as a sole aetiology, but more so and as a co-factor in mixed-aetiology HCC

MAFLD is closely linked to an increased risk of atherosclerotic cardiovascular disease (ASCVD), reflecting a significant concern given the global prevalence of both conditions. MAFLD and ASCVD share common metabolic risk factors including obesity, insulin resistance.

Read it here 👇🏼

doi.org/10.1111/liv.15…

#ALEH #EASL #AASLD #AGA #ACG #APASL #AMG   #MAIDEN #AMH

🚨 An interesting article on the role of white adipose tissue in #MAFLD

📌 White adipose tissue plays a key role in the interaction of inflammation and insulin resistance!

➡️ #MAFLD ⬆️ risk of chronic kidney disease, both in children and adults.‼️
➡️ A complex inter-organ crosstalk sustained by metabolic dysfunction is underlying mechanism.
➡️ Multidisciplinary approach to managing MAFLD is needed.
👉 Find out more wjgnet.com/1007-9327/core…

Findings from our study indicate that MAFLD was identified in 47.7% of participants and MASLD in 45.2%. Crucially, MAFLD was independently associated with a significantly higher risk of ASCVD.

Please do not forget everything that makes your liver looks like this that you have the power to change:
1. Alcohol
2. Hepatitis C virus
3. Hepatitis B virus
4. Metabolic dysfunction associated fatty liver disease.
👉maiden-apasl.com/patients-resou…
#livertwitter #medtwitter #MAFLD

These overlapping risk factors suggest that the pathophysiological processes driving MAFLD may also contribute to the development of atherosclerosis and other cardiovascular complications.

🚨 Can we predict CVD risk early in patients with #MAFLD ?🤔

📌 A novel predictive model based on metabolites and some clinical parameters could effectively discriminate MAFLD patients with CVD risk at a very early stage.

👉 sciencedirect.com/science/articl…

🆕 study; 3553 participants; FU 4Y
📌83.13% of participants with #MAFLD had normal ALT levels.
📌Long-term high-normal ALT levels were associated with ~ 1.5 fold increased risk of new-onset MAFLD.
wjgnet.com/1007-9327/full…